Synergistic antiproliferation action of the flavonols quercetin and kaempferol in cultured human cancer cell lines

In Vivo

Volumn 19, Issue 1, 2005, Pages 69-76

  Leigh Ackland, Margaret ^a   Van De Waarsenburg, Simone ^a   Jones, Rod ^b  

^a DEAKIN UNIVERSITY   (Australia)

^b DEPARTMENT OF PRIMARY INDUSTRIES   (Australia)

Author keywords

Anticancer effects; Flavonols; Human cells

Indexed keywords

CELL PROTEIN; FLAVONOL DERIVATIVE; KAEMPFEROL; KI 67 ANTIGEN; QUERCETIN;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL COUNT; CELL NUCLEUS; CELL PROLIFERATION; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG EFFICACY; DRUG EXPOSURE; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; INTESTINE CANCER;

EID: 16244422650     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Steinmetz KA and Potter JD: Vegetables, fruit and cancer. 1. Epidemiology. Cancer Causes Control 2: 325-357, 1991.
2. Cox BD, Whichelow MJ and Prevost AT: Seasonal consumption of salad vegetables and fresh fruit in relation to the development of cardiovascular disease and cancer. Public Health Nutr 3(1): 19-29, 2000.
3. Reddy L, Odhav B and Bhoola KD: Natural products for cancer prevention: a global perspective. Pharmacol Ther 99(1): 1-13, 2003.
4. Knekt P, Jarvinen R, Seppanen R et al: Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 146: 223-30, 1997.
5. Stefani ED, Boffetta P, Deneo-Pellegrini H et al: Dietary antioxidants and lung cancer risk: a case-control study in Uruguay. Nutr Cancer 34: 100-110, 1999.
6. Hertog MGL, Hollman PCH and Katan MJ: Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J Agric Food Chem 40: 2379-2383, 1992.
7. Hollman PCH and Katan MB: Dietary flavonoids: intake, health effects and bioavailability. Food Chem Toxicol 37: 937-942, 1999.
8. Paganga G and Rice-Evans CA: The identification of flavonoids as glycosides in human plasma. FEBS Lett 401: 78-82, 1997.
9. 2 production. Circulation 105: e53, 2002.
10. Murota K and Terao J: Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch Biochem Biophys 417: 12-7, 2003.
11. Day AJ, Bao Y, Morgan MRA and Williamson G: Conjugtion position of quercetin glucuronides and effect on biological activity. Free Radical Biol Med 29: 1234-1243, 2000.
12. O'Leary KA, Day AJ, Needs PW et al: Flavonoid glucuronides are substrates for human liver β-glucuronidase. FEBS Lett 503: 103-106, 2001.
13. Yang K, Lamprecht SA, Liu Y et al: Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon. Carcinogenesis 21: 1655-1660, 2000.
14. Deschner EE, Ruperto J, Wong G et al: Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis 12: 1193-1196, 1991.
15. Verma AK, Johnson JA, Gould MN et al: Inhibition of 7,12 dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin. Cancer Res 48: 5754-5758, 1988.
16. Knowles LM, Zigrossi DA, Tauber RA et al: Flavonoids suppress androgen-independent human prostate tumor proliferation. Nutr Cancer 38: 116-22, 2000.
17. So FV, Guthrie N, Chambers AF et al: Inhibition of proliferation of estrogen receptor positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen. Cancer Lett 112: 127-133, 1997.
18. Elattar TM and Virji AS: The inhibitory effect of curcumin, genistein, quercetin and cisplatin on the growth of oral cancer cells in vitro. Anticancer Res 20: 1733-8, 2000.
19. Assaum J, Matsuzaki H, Kuroda M, Takeda Y, Kishi K and Hiraki Y: Effects of quercetin on the cell growth and the intracellular accumulation and retention of adriamycin. Anticancer Res 20: 2477-2483, 2000.
20. Yoshida M, Sakai T, Hosokawa N et al: The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett 260: 10-13, 1990.
21. Agullo G, Gamet L, Besson C et al: Quercetin exerts a preferential cytotoxic effect on active dividing colon carcinoma HT29 and Caco-2 cells. Cancer Lett 87: 55-63, 1994.
22. Hosokawa N, Hosokawa Y, Sakai T et al: Inhibitory effect of quercetin on the synthesis of a possibly cell-cycle-related 17-kDa protein, in human colon cancer cells. Int J Cancer 45: 1119-1124, 1990.
23. Ranelletti FO, Ricci R, Larocca LM et al: Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors. Int J Cancer 50: 486-492, 1992.
24. Lee SC, Kuan CY, Yang CC and Yang SD: Bioflavonoids commonly and potently induce tyrosine dephoshorylation/inactivation of oncogenic proline-directed protein kinase FA in human prostate cancer cells. Anticancer Res 18: 1117-1121, 1998.
25. Weber G, Shen F, Prajda N, Yeh YA, Yang H, Herenyiova M and Look KY: Increased signal transduction activity and down-regulation in human cancer cells. Anticancer Res 16: 3271-3282, 1996.
26. Casagrande F and Darbon JM: Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1. Biochem Pharmacol 61: 1205-15, 2001.
27. Pignatelli P, Pulcinelli FM, Celestini A et al: The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonising the intracellular production of hydrogen peroxide. Am J Clin Nutr 72: 1150-1155, 2000.
28. Chan MM, Mattiacci JA, Hwang HS et al: Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway. Biochem Pharmacol 60(10): 1539-48, 2000.
29. Koren R, Rocker D, Kotestiano O et al: Synergistic anticancer activity of 1,25-dihydroxyvitamin D(3) and immune cytokines: the involvement of reactive oxygen species. J Steroid Biochem Mol Biol 73(3-4): 105-12, 2000.
30. Lonn E, Yusef S, Hoogwerf B et al: Effects of Vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and the MICROHOPE substudy. Diabetes Care 25: 1919-1927, 2002.
31. Omenn GS, Goodman GE, Thornquist MD et al: Effects of a combination of beta-carotene and Vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334: 1150-1155, 1996.
32. Michalczyk AA, Allen J, Blomeley RC et al: Constitutive expression of hZnT4 zinc transporter in human breast epithelial cells. Biochem J 364(Pt 1): 105-13, 2002.
33. Chan MM, Mattiacci JA, Hwang HS et al: Synergy between ethanol and grape polyphenols, quercetin and resveratrol in the inhibition of the inducible nitric oxide synthase pathway. Biochem Pharmacol 60: 1539-48, 2000.
34. Nho CW and Jeffery E: The synergistic upregulation of phase II detoxification enzymes by glucosinolate breakdown products in cruciferous vegetables. Toxicol Appl Pharmacol 174: 146-152, 2001.
35. Kuo SM: Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett 110: 41-48, 1996.
36. Chang WS, Lee YJ Lu FJ and Chiang HC: Inhibitory effects of flavonoids on xanthine oxidase. Anticancer Res 13: 2165-2170, 1993.